Increased transforming growth factor (TGF)β receptor signalling and decreased Bone morphogenetic protein receptor type II (BMPR2) signalling were shown to contribute to PAH pathogenesis [29]. Here, BMPR2 is linked to pulmonary arterial hypertension.